Association of C-reactive Protein with Cardiovascular Outcomes: A Mendelian Randomization Study in the Japanese

Ming Yang Cao1, Di Liu2, Xiao Yu Zhang3

  • 1Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing 100069, China.

Insights

C-reactive protein (CRP) shows no causal link to stroke, atrial fibrillation, or arrhythmia. Suggestive evidence links CRP to congestive heart failure, warranting further investigation into this cardiovascular disease risk.

Area of Science:

  • Cardiovascular Epidemiology
  • Genetic Epidemiology
  • Biomarkers

Background:

  • C-reactive protein (CRP) is linked to cardiovascular disease (CVD) risk in observational studies.
  • The causal relationship between CRP and specific cardiovascular outcomes remains uncertain.

Purpose of the Study:

  • To investigate the potential causal effect of C-reactive protein (CRP) on cardiovascular outcomes.
  • To examine the causal association between genetically predicted CRP levels and ischemic stroke, atrial fibrillation, arrhythmia, and congestive heart failure.

Main Methods:

  • Two-sample Mendelian randomization (MR) analysis using summary statistics from the Japanese Encyclopedia of Genetic association by Riken (JENGER).
  • Four single-nucleotide polymorphisms (SNPs) associated with CRP levels were utilized as instrumental variables.
  • Inverse-variance weighted (IVW), penalized weighted median, and weighted median methods were employed for MR estimation, with MR-Egger regression assessing pleiotropy.

Main Results:

  • No significant causal association was detected between genetically determined CRP levels and ischemic stroke, atrial fibrillation, or arrhythmia across all MR methods.
  • The IVW method suggested a potential causal link between CRP and congestive heart failure (OR: 1.337, P=0.046), though not consistently supported by other methods.
  • No substantial evidence of pleiotropy or heterogeneity was observed in the analyses.

Conclusions:

  • Mendelian randomization analysis provides suggestive evidence for a causal association between C-reactive protein and congestive heart failure.
  • No causal relationship was established between CRP and ischemic stroke, atrial fibrillation, or arrhythmia.
  • Further research is recommended to confirm the link between CRP and congestive heart failure.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
247
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
96
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
142
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
462
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
753
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
383